Canada · Delayed Price · Currency is CAD Draganfly Earnings Call Transcripts
Fiscal Year 2025
-
Record 2025 revenue grew 17.8% to $7.7M, driven by new product launches and military contracts, but losses widened due to higher costs and inventory write-downs. Strong cash position and strategic partnerships position the company for global expansion and future growth.
-
Q3 2025 revenue rose 14.4% year-over-year to CAD 2.16 million, with military orders set to drive future growth. Cash balance reached CAD 69.9 million, and production capacity is expanding rapidly to meet surging demand.
-
Q2 revenue grew 22% YoY and 37% sequentially, with gross margin at 24% and cash reserves rising to $68M after financings. Major defense and public safety contracts, product innovation, and strategic partnerships drove growth, positioning the company for further expansion.
-
The meeting confirmed quorum, approved all agenda items as outlined in the Notice of Meeting, and concluded without objections or further business raised by shareholders.
-
Q1 revenue grew 16% year-over-year to $1.5M, with gross profit at $310K and a comprehensive loss of $3.4M. Major partnerships, new product launches, and a $3.6M financing position the company for significant growth, with large contracts expected to drive profitability in 2026.
Fiscal Year 2024
-
Q4 revenue jumped 76% year-over-year as new plant capacity came online, while full-year revenue was flat due to earlier constraints. Losses narrowed significantly, cash reserves grew, and major government and medical contracts advanced, positioning the company for future growth.
-
Q3 revenue reached CAD 1.9 million, with strong demand for FPV, APEX, and Commander 3XL drones. Adjusted gross margin was 32.7%, and cash rose to CAD 4 million. Outlook for Q4 is highly optimistic, with major opportunities expected.
-
Q2 revenue rose 30% sequentially to $1.7M, with improved gross margin and reduced operational burn. Major contracts, new board members, and product launches position the company for growth in military and commercial markets.
-
The meeting confirmed quorum, approved six directors, and reappointed auditors for the next year. Audited financials for 2023 were presented, and no shareholder questions were raised during the Q&A.